About the Company

Medpace is a leading full-service clinical research organization (CRO) headquartered in Cincinnati, Ohio, accelerating biopharma innovation through Phase I-IV clinical development, laboratory services, and regulatory consulting for 400+ global sponsors generating $2B+ FY2025 revenue. Specializing in rare diseases, oncology, and CNS therapeutics, Medpace delivers 2x faster study timelines through integrated lab services and medical imaging expertise serving biotech and pharma worldwide.